Overview

An Exploratory Study of Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants Rivaroxaban in Patients With Left Ventricular Thrombus

Status:
Recruiting

Trial end date:
2023-12-30

Target enrollment:

Participant gender:

Summary

To study the effect of rivaroxaban anticoagulant therapy for 12 weeks in patients with left ventricular mural thrombus by contrast echocardiography before and after treatment, so as to provide basis and foundation for further study and treatment selection in the future; To provide further relevant data for the treatment outcome, treatment duration and influencing factors of left ventricular mural thrombosis; It is of great sociological and health economic significance to find more effective and safe anticoagulant treatment strategies for patients with left ventricular mural thrombosis, which will reduce the incidence of embolism and bleeding.

Phase:

N/A

Details

Lead Sponsor:

China National Center for Cardiovascular Diseases

Treatments:

Rivaroxaban